NorthWest Biotherapeutics Inc (NWBO)

[WJR61]

The 30-45 day suggested timeline for submission and acceptance may be a little optimistic. This sounds more like 180 days, or the end of February 2024, for both. Hope you are right, though.

Northwest Bio Accuses Market Makers of Share Price Manipulation
TR
Northwest Biotherapeutics plans to submit a Marketing Authorization
Application in the U.K., to the Medicines and Healthcare Products
Regulatory Agency for commercial approval of the Company's DCVax-L
treatment for glioblastoma. The Company believes that it has now
completed all of the remaining prerequisites for such an application,
including certain steps related to implementation of the approved Pediatric
Investigation Plan and submission of the required formal notification to the
MHRA of the upcoming MAA. As the Company reported in its recent 10-Q
filing, the Company is in the final stages of completing the application
package itself. The Company anticipates submitting the MAA in
approximately the next 30-45 davs The Company plans to request that the
MHRA review the MAA under the 150-business day process that the MHRA
has established to accelerate the availability of new medicines for patients
in the U.k.
News